help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinlaw, W. B.
Right arrow Articles by Oppenheimer, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinlaw, W. B.
Right arrow Articles by Oppenheimer, J. H.

Endocrinology, Vol 123, 2255-2260, Copyright © 1988 by Endocrine Society


ARTICLES

Triiodothyronine rapidly reverses inhibition of S14 gene transcription by glucagon

WB Kinlaw, HL Schwartz, PS Hamblin, CN Mariash and JH Oppenheimer
Department of Medicine, University of Minnesota, Minneapolis 55455.

The rapid response of hepatic mRNA-S14 to T3 has made this sequence an important model for studying the mechanism of hormonal induction of gene expression. In previous studies we showed, in the intact rat, that glucagon administration during the peak of the mRNA S14 diurnal rhythm causes a monoexponential fall in the level of mRNA-S14, and that T3 reverses this effect. We have now defined more precisely the mechanism governing this interaction. Measurement of in vitro nuclear transcriptional rates shows that T3 can reverse the glucagon-induced reduction of mRNA-S14 transcription. Reversal can be demonstrated within 5 min after the iv injection of T3. Further, the reversal appears to be related to the occupation of specific nuclear receptors, as inferred from the calculated nuclear occupancy and the effects of various iodothyronine analogs of T3. These results suggest that the effects of T3 are mediated by varying rates of production of the nuclear precursor and not by its stabilization, as previously proposed. Ancillary evidence supporting this conclusion came from the demonstration that the apparent t1/2 of the 4.5-kilobase precursor was not prolonged by T3.


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Hernandez, B. Garcia, and M.-J. Obregon
Gene Expression from the Imprinted Dio3 Locus Is Associated with Cell Proliferation of Cultured Brown Adipocytes
Endocrinology, August 1, 2007; 148(8): 3968 - 3976.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
SuzanneB. Brown, M. Maloney, and WilliamB. Kinlaw
"Spot 14" Protein Functions at the Pretranslational Level in the Regulation of Hepatic Metabolism by Thyroid Hormone and Glucose
J. Biol. Chem., January 24, 1997; 272(4): 2163 - 2166.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. B. Kinlaw, J. L. Church, J. Harmon, and C. N. Mariash
Direct Evidence for a Role of the ``Spot 14'' Protein in the Regulation of Lipid Synthesis
J. Biol. Chem., July 14, 1995; 270(28): 16615 - 16618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society